Dipal Doshi

CIK 1613084 · CEO · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.62M

Companies

3

Total Filings

46

Lifetime Open-Market Net

-$1.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRDA CEO 526,014 $6.46 $3.40M -$1.39M 40 2026-03-03
AZTA Director 9,703 $22.59 $219.2K $0 2 2026-02-06
AMICUS THERAPEUTICS, INC. (FOLD) Delisted SVP Strategy & Bus Dev 1,706 $14.49 $24.7K -$86.7K 4 2015-07-09

Recent Filings · Page 2 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-02-20 TRDA Sell (S) −1,000 -$15.0K EDGAR
2024-01-18 TRDA Sell (S) −1,000 -$16.0K EDGAR
2023-12-22 TRDA Sell (S) −1,000 -$15.0K EDGAR
2023-11-13 TRDA Sell (S) −1,000 -$16.2K EDGAR
2023-10-19 TRDA Sell (S) −1,000 -$15.0K EDGAR
2023-09-15 TRDA Sell (S) −1,000 -$15.0K EDGAR
2023-09-06 TRDA Mixed +48,210 -$20.8K EDGAR
2023-08-16 TRDA Sell (S) −1,000 -$15.7K EDGAR
2023-05-01 TRDA Sell (S) −2,000 -$27.4K EDGAR
2023-04-19 TRDA Grant (A) +49,650 $0 EDGAR
Showing 1120 of 46
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.